Benmedica
benmedica.com
EHR & Clinical Software
Pharmacies
Health Care
As featured in
Claim pageClaim
Follow
Overview
Connections
News
Salaries
Products
People
Growth
Offices
Financials
Overview
Driving Clarity, Performance, and Affordability in Medication Benefits Schedule a Meeting Let's Connect Request Information Transforming Medication Benefits Through Data Intelligence and Integration Benmedica was built on the belief that medication benefits can—and should—work better.
Connections
List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors
Capital InnovatorsVia a fund
Click a company to open it. Dashed lines are likely connections. The second step of the network is part of the Pro plan.
Owner
Same company
Same group
Likely
News
AI in Healthcare: Beyond the Hype by Driving Operational Efficiency and Trust
By Bryan Odegard, CEO, Benmedica Artificial Intelligence (AI) dominates headlines in healthcare from Nvidia's strategic expansion into medical AI, to policy volatility shaking up biotech investment. But beneath the noise lies a quieter, more foundational
Read more
Report
Nvidia's healthcare boss talks changes coming to doctors' offices - and which companies may get a boost and lower costs
Nvidia's healthcare strategy leverages AI to revolutionize medical imaging and diagnostics, according to healthcare GM Kimberly Powell.
Read more
Report
Smarter ePrescribing with BenCore eRx+ and NCPDP v60
Discover how Benmedica's BenCore eRx+ and Precision F&B turn compliance into strategic value through smarter, clearer, and cost-effective prescribing. The industry has made strides with ePrescribing but static formulary data, inconsistent alternatives, an
Read more
Report
Savings by a Thousand Cuts: Hidden Value in Drug Alternatives
At Benmedica, we call this "savings by a thousand cuts"- the incremental, often-overlooked savings opportunities that, when combined, create meaningful financial impact across the healthcare system. Recent research highlights the urgency of addressing pre
Read more
Report
Alternatives For Formulary Drug Alternatives
Alternatives for Formulary Drug Alternatives! Proactive work on the part of payers can make drug alternatives that appear in EHRs Electronic Health Record systems (EHRs) more useful and resolve differences between alternatives displayed using Formulary &
Read more
Report
Better Together: Comparing Real-Time Pharmacy Benefit Checks to Formulary and Benefit Data in EHRs
While real-time pharmacy benefit checks are increasingly touted as the answer to formulary needs within Electronic Health Record systems (EHRs), prescribers and patients often require additional information to develop effective treatment plans. High-quali
Read more
Report
Improvements to Formulary Data on the Horizon
Exciting changes are coming to NCPDP's Formulary and Benefit Standard (F&B), and we are reviewing the changes here. This update to the existing standard responds to market events like indication-based formulary designs, clearer formulary statuses and pric
Read more
Report
Engaging All Healthcare Stakeholders Across Rx Saving Opportunities
Pharmacy Benefit Managers (PBMs), prescribers, and pharmacists all play a crucial but different role in communicating prescription savings opportunities to patients. PBMs work with their clients to create plan designs and provide data to other parties tha
Read more
Report
Physician Perspectives of Real Time Benefit Tools: The right information at the wrong time?
Congress mandated that Medicare Part D plans provide patient cost information to physicians in their EHRs. These Real Time Benefit Tools (RTBT) have been rolled out to physicians through various EHR system updates. A study published in November 2022 in th
Read more
Report
8 Best Practices for Using Drug Alternatives to Create Drug Cost Savings
In a recent article, we compared the drug alternatives information provided by seven Pharmacy Benefit Managers (PBMs) to understand how useful that information is for supporting prescription decisions. We noted that there are several areas where improving
Read more
Report
Show more news